• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Fresenius Kabi launches Dilaudid injection in Simplist prefilled syringes

February 17, 2017 By Sarah Faulkner

FreseniusFresenius Kabi launches Dilaudid injection in Simplist prefilled syringes (NYSE:FMS) business group Fresenius Kabi said today that its Dilaudid hydromorphone HCl injection is available in 4 different presentations of the Simplest prefilled syringes.

The Lake Zurich-Ill. company’s Simplist syringes have a 2-year shelf life and do not require any assembly or point-of care preparation.

The prefilled syringes sport different colors associated with different dose strengths and are clearly labelled to avoid confusion between hydromorphone and morphine, Fresenius Kabi said.

“Medication errors due to ‘look-alike’ and ‘sound-alike’ names are real, well documented and can have tragic outcomes for patients,” president & CEO John Ducker said in prepared remarks. “Fresenius Kabi Simplist Dilaudid prefilled syringes can help prevent name confusion between hydromorphone and morphine and to assist health care professionals in delivering the right medication to their patients.”

In December last year, Fresenius Kabi said that it added its heparin sodium injection to the company’s Simplist prefilled syringe portfolio. The prefilled syringe for subcutaneous and intravenous bolus injections expands Fresenius Kabi’s available Heparin formulations.

Earlier that month, the company said it landed a 5-year exclusive distribution deal with Terumo Corp. (TYO:4543) to launch Fresenius’ CATSmart autotransfusion system in the US.

Fresenius said that its CATSmart autotransfusion device, which re-infuses a surgical patient’s own blood, boasts continuous-flow technology, 3 wash programs, an auto-start function and sensors for automatic processing. The companies did not release the terms of the deal, but Terumo Cardiovascular will distribute the devices throughout the U.S.

Filed Under: Drug-Device Combinations, Featured, Pain Management, Wall Street Beat Tagged With: Fresenius

IN CASE YOU MISSED IT

  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS